
Invitae Corporation NVTA
Quartalsbericht 2023-Q3
hinzugefügt 08.11.2023
Invitae Corporation Finanzkreislauf 2011-2026 | NVTA
Finanzkreislauf Jährlich Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 299 | 201 | 55.2 | 22.9 | 29.4 | -6.89 | -43.9 | -77.3 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 299 | -77.3 | 59.9 |
Finanzkreislauf Vierteljährlich Invitae Corporation
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60 | 67.4 | 82.8 | - | 74.9 | 64.4 | 60.7 | 48.7 | 42.4 | 34.8 | 40.2 | 52.5 | 76.7 | 109 | 60.6 | 35.6 | 42 | 43.4 | 59.3 | 55 | 66.4 | 66.5 | 53.7 | 5.83 | -6.76 | -8.52 | -7.4 | 11.4 | -25.5 | -28.4 | -38.9 | - | -80.8 | -82.6 | -90.7 | - | -155 | -271 | -214 | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 109 | -271 | 8.47 |
Finanzkreislauf anderer Aktien in der Diagnostik & Forschung
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | ||
|
Agilent Technologies
A
|
111 | $ 116.92 | 2.68 % | $ 35.5 B | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | ||
|
Castle Biosciences
CSTL
|
45.9 | $ 25.62 | 3.18 % | $ 712 M | ||
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
Danaher Corporation
DHR
|
77.5 | $ 195.29 | 2.24 % | $ 139 B | ||
|
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
42.4 | $ 16.25 | 2.14 % | $ 491 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 18.15 | 2.72 % | $ 967 M | ||
|
Guardant Health
GH
|
79.6 | $ 94.73 | 1.53 % | $ 11.9 B | ||
|
DexCom
DXCM
|
134 | $ 65.41 | 3.64 % | $ 25.5 B | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | ||
|
Burning Rock Biotech Limited
BNR
|
149 | $ 16.5 | 2.52 % | $ 178 M | ||
|
Co-Diagnostics
CODX
|
-2.46 K | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
ICON Public Limited Company
ICLR
|
62 | $ 108.69 | 1.43 % | $ 8.97 B | ||
|
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | ||
|
Illumina
ILMN
|
142 | $ 127.4 | 0.76 % | $ 20.3 B | ||
|
IQVIA Holdings
IQV
|
73.9 | $ 174.05 | 2.06 % | $ 29.9 B | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 274.58 | 2.01 % | $ 22.8 B | ||
|
Lantheus Holdings
LNTH
|
97.3 | $ 79.47 | 1.78 % | $ 5.36 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 176.29 | 3.94 % | $ 8.74 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 522.84 | 2.82 % | $ 15.1 B | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 318.82 | 3.84 % | $ 27.2 B | ||
|
Myriad Genetics
MYGN
|
49.3 | $ 4.87 | 2.64 % | $ 451 M | ||
|
Biodesix
BDSX
|
41.7 | $ 14.75 | 1.48 % | $ 1.91 B | ||
|
NeoGenomics
NEO
|
82.4 | $ 8.36 | 3.72 % | $ 1.07 B | ||
|
Neogen Corporation
NEOG
|
150 | $ 10.53 | 5.51 % | $ 2.28 B | ||
|
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M | ||
|
Natera
NTRA
|
81.5 | $ 212.64 | 1.61 % | $ 20.9 B | ||
|
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | ||
|
Pacific Biosciences of California
PACB
|
185 | $ 1.5 | 3.82 % | $ 450 M | ||
|
Quotient Limited
QTNT
|
345 | - | -11.32 % | $ 1.1 M | ||
|
Precipio
PRPO
|
19.9 | $ 28.4 | -0.37 % | $ 45.6 M | ||
|
Personalis
PSNL
|
-11.5 | $ 6.5 | 5.35 % | $ 385 M | ||
|
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
275 | $ 2.68 | -0.56 % | $ 87 K | ||
|
Biomerica
BMRA
|
172 | $ 2.14 | -0.93 % | $ 4.92 M | ||
|
BioNano Genomics
BNGO
|
166 | $ 1.17 | 0.17 % | $ 6.37 M | ||
|
Interpace Biosciences
IDXG
|
62.9 | $ 2.0 | 0.25 % | $ 8.85 M |